Xenon Pharmaceuticals Inc (XENE)
38.83
-0.65
(-1.65%)
USD |
NASDAQ |
Dec 27, 16:00
40.00
+1.17
(+3.01%)
After-Hours: 20:00
Xenon Pharmaceuticals Cash from Investing (Quarterly): 1.98M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | -10.57M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -0.0696M |
| ESSA Pharma Inc | 21.02M |
| ImmunoPrecise Antibodies Ltd | -0.0482M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -51.15M |
| Free Cash Flow | -158.99M |
| Free Cash Flow Per Share (Quarterly) | -0.6639 |
| Free Cash Flow Yield | -5.40% |